Elevate Uranium Valuation

EL8 Stock   0.24  0.03  14.29%   
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Elevate Uranium prevailing Real Value cannot be determined due to lack of data. The current price of Elevate Uranium is USD0.24. Our model computes the value of Elevate Uranium from reviewing the firm fundamentals such as Shares Owned By Insiders of 19.38 %, price to sales of 497,911 X, and Current Valuation of 54.84 M as well as analyzing its technical indicators and probability of bankruptcy.
Undervalued
Today
0.24
Please note that Elevate Uranium's price fluctuation is out of control at this time. Calculation of the real value of Elevate Uranium is based on 3 months time horizon. Increasing Elevate Uranium's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Elevate Uranium's intrinsic value may or may not be the same as its current market price of 0.24, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.24 Real  0.0 Hype  0.0 Naive  0.25
The intrinsic value of Elevate Uranium's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Elevate Uranium's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
0.00
Real Value
5.45
Upside
Estimating the potential upside or downside of Elevate Uranium helps investors to forecast how Elevate stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Elevate Uranium more accurately as focusing exclusively on Elevate Uranium's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.190.230.27
Details
Hype
Prediction
LowEstimatedHigh
0.000.005.45
Details
Naive
Forecast
LowNext ValueHigh
00.255.70
Details

Elevate Uranium Total Value Analysis

Elevate Uranium is currently forecasted to have takeover price of 54.84 M with market capitalization of 90.62 M, debt of 74.21 K, and cash on hands of 10.06 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Elevate Uranium fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
54.84 M
90.62 M
74.21 K
10.06 M

Elevate Uranium Investor Information

About 19.0% of the company shares are held by company insiders. The book value of Elevate Uranium was currently reported as 0.07. The company recorded a loss per share of 0.04. Elevate Uranium had not issued any dividends in recent years. The entity had 1:100 split on the 5th of November 2014. Elevate Uranium is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.

Elevate Uranium Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Elevate Uranium has an asset utilization ratio of 0.001373 percent. This implies that the Company is making USD1.4E-5 for each dollar of assets. An increasing asset utilization means that Elevate Uranium is more efficient with each dollar of assets it utilizes for everyday operations.

Elevate Uranium Ownership Allocation

Elevate Uranium holds a total of 385.62 Million outstanding shares. 30% of Elevate Uranium outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Elevate Uranium Profitability Analysis

The company reported the revenue of 182. Net Loss for the year was (10.75 M) with profit before overhead, payroll, taxes, and interest of 182.

About Elevate Uranium Valuation

The stock valuation mechanism determines Elevate Uranium's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Elevate Uranium based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Elevate Uranium. We calculate exposure to Elevate Uranium's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Elevate Uranium's related companies.

Additional Tools for Elevate Stock Analysis

When running Elevate Uranium's price analysis, check to measure Elevate Uranium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevate Uranium is operating at the current time. Most of Elevate Uranium's value examination focuses on studying past and present price action to predict the probability of Elevate Uranium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevate Uranium's price. Additionally, you may evaluate how the addition of Elevate Uranium to your portfolios can decrease your overall portfolio volatility.